Last reviewed · How we verify
NovaBay Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
7 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Dermatology · 1
- Infectious Diseases · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Armata Pharmaceuticals, Inc. · 1 shared drug class
- Krishnadevaraya College of Dental Sciences & Hospital · 1 shared drug class
- Riyadh Colleges of Dentistry and Pharmacy · 1 shared drug class
- SIFI SpA · 1 shared drug class
- Savara Inc. · 1 shared drug class
- Universitair Ziekenhuis Brussel · 1 shared drug class
- University of Guarulhos · 1 shared drug class
- VA Office of Research and Development · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for NovaBay Pharmaceuticals, Inc.:
- NovaBay Pharmaceuticals, Inc. pipeline updates — RSS
- NovaBay Pharmaceuticals, Inc. pipeline updates — Atom
- NovaBay Pharmaceuticals, Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). NovaBay Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/novabay-pharmaceuticals-inc. Accessed 2026-05-16.